Bioverativ Therapeutics, Inc.
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 12
- DOL-certified
- 91.7%
- Median offered wage
- $113,818
Waltham, MA NAICS: 32541
How many H-1B LCA filings list Bioverativ Therapeutics, Inc.?
U.S. Department of Labor's OFLC discloses 12 Labor Condition Application filings naming Bioverativ Therapeutics, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
How many H-1B petitions has USCIS approved for Bioverativ Therapeutics, Inc.?
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 40 H-1B petitions naming Bioverativ Therapeutics, Inc. through FY2023, and approved nearly every one of them: 97.5% approved (39 approvals, 1 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
Bioverativ Therapeutics, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
12 16712th of 122824 higher than 106,112 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Headquartered in Waltham, MA. Methodology.
LCA filing shape · Bioverativ Therapeutics, Inc.
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $79,581–$167,253 .
Title concentration
- Senior Associate Scientist, Rare Blood Disorders 3 · 25% · $93,150
- Scientist, Complement Research 2 · 16.7% · $108,410
- Scientist 2 · 16.7% · $102,721
- Senior Associate Scientist, Research 1 · 8.3% · $79,581
- Principal Scientist 1 · 8.3% · $143,686
Worksite counties
- CAMBRIDGE CITY, MA 6 · 66.7%
- WALTHAM CITY, MA 3 · 33.3%
Local thin filer
Bioverativ Therapeutics, Inc. (Waltham, MA) has 12 disclosed LCA s with worksites in a single state on this extract. Top title: Senior Associate Scientist, Rare Blood Disorders. Small-N percentages swing hard on one withdrawn filing.
Recent LCA Filings
Latest H-1B labor condition applications filed by Bioverativ Therapeutics, Inc.
| Job Title | Location | Salary | Status | Year |
|---|---|---|---|---|
| Clinical Supply Chain Project Leader | Waltham, MA | $167,253 | Certified | FY2026 |
| Senior Associate Scientist, Research | Cambridge, MA | $79,581 | Certified | FY2026 |
| Scientist | Cambridge, MA | $101,026 | Certified | FY2025 |
| Scientist | Waltham, MA | $104,416 | Certified | FY2025 |
| Clinical Supply Project Operational Leader | Waltham, MA | $141,149 | Certified | FY2023 |
| Senior Associate Scientist, Rare Blood Disorders | Cambridge, MA | $93,150 | Certified | FY2023 |
| IT Lead | Cambridge, MA | $132,434 | Certified | FY2023 |
| Senior Associate Scientist, Rare Blood Disorders | Cambridge, MA | $93,150 | Withdrawn | FY2023 |
| Senior Associate Scientist, Rare Blood Disorders | Cambridge, MA | $93,150 | Certified - Withdrawn | FY2023 |
| Principal Scientist | Waltham, MA | $143,686 | Certified | FY2023 |
| Scientist, Complement Research | Cambridge, MA | $108,410 | Certified | FY2023 |
| Scientist, Complement Research | Cambridge, MA | $108,410 | Certified | FY2023 |
Nationwide peers near Bioverativ Therapeutics, Inc.'s 12-LCA band
Cross-state DOL neighbors for Bioverativ Therapeutics, Inc. - LCA filing-count and offered-wage axes, outside MA.
Similar LCA filing volume
Nearest cross-state employer filers by LCA filing count (12 here; floor ≥10 LCA filings).
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($113,818 here).
Frequently Asked Questions
How many H-1B LCA filings list Bioverativ Therapeutics, Inc.?
Bioverativ Therapeutics, Inc. is listed in 12 DOL Labor Condition Application filings covering 12 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
How does Bioverativ Therapeutics, Inc.'s LCA filing volume compare to other employer filers?
Among 122,824 employer filers in the DOL disclosure extract, Bioverativ Therapeutics, Inc. ranks #15675 by total LCA filing count (12 filings). 106,112 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
What is the H-1B DOL certification rate for Bioverativ Therapeutics, Inc.?
Bioverativ Therapeutics, Inc. has a 91.7% DOL certification rate, with 11 out of 12 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
What offered wage is listed in LCAs for Bioverativ Therapeutics, Inc.?
The average offered wage listed in Bioverativ Therapeutics, Inc.'s LCAs is $113,818. Listed wages range from $79,581 to $167,253 and are not verified actual compensation.
What are the most common H-1B job titles at Bioverativ Therapeutics, Inc.?
The top job titles in Bioverativ Therapeutics, Inc.'s LCA filing records include Senior Associate Scientist, Rare Blood Disorders, Scientist, Complement Research, Scientist. The most common listed title is Senior Associate Scientist, Rare Blood Disorders with 3 LCA filings at an average listed offered wage of $93,150. This does not establish actual job openings, hiring, or approved petitions.
Where is Bioverativ Therapeutics, Inc. located?
Bioverativ Therapeutics, Inc. is headquartered in Waltham, MA.
Is Bioverativ Therapeutics, Inc. H-1B dependent?
No, Bioverativ Therapeutics, Inc. is not classified as H-1B dependent.
How have Bioverativ Therapeutics, Inc.'s listed LCA filings changed over time?
Bioverativ Therapeutics, Inc. is listed in 8 LCA filings in FY2023 and 2 in FY2026. The average listed offered wage increased from $114,192 to $123,417. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
Read with Bioverativ Therapeutics, Inc.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-SOLID · WAGE-PAR.
ABS(total_petitions) peer at 12 LCAs (Δ 0 heavier vs Bioverativ Therapeutics, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-SOLID · WAGE-PAR.
ABS(total_petitions) peer at 12 LCAs (Δ 0 heavier vs Bioverativ Therapeutics, Inc.); CERT-LOCK · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-SOLID · WAGE-PAR.
ABS(total_petitions) peer at 12 LCAs (Δ 0 heavier vs Bioverativ Therapeutics, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-SOLID · WAGE-PAR.
ABS(total_petitions) peer at 12 LCAs (Δ 0 heavier vs Bioverativ Therapeutics, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-SOLID · WAGE-PAR.
MA pole at 3,809 LCAs stamps HEAVY-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Bioverativ Therapeutics, Inc.'s MICRO-BOOK.
Open the MA state board after the ABS peers. Bioverativ Therapeutics, Inc. stamps MICRO-BOOK · CERT-SOLID inside that worksite mix.
Bioverativ Therapeutics, Inc.'s CERT-SOLID stamp sits below CERT-CLEAN. Start with how LCA certification works.
What to do with this profile
Use the DOL LCA record for Bioverativ Therapeutics, Inc. to compare filing volume and offered wages, not USCIS outcomes.
- Bioverativ Therapeutics, Inc. filed 12 LCAs in the indexed extract (91.7% certified in-file). That volume ranks higher than 87% of employer filers.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in MA rank on LCA filing volume this vintage. MA filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.